CancerVax Corporation
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vaccine Therapy in Treating Patients With Malignant Melanoma (NCT00128583) | CancerVax Corporation | 2005-07-01 |
| Vaccine Therapy for Patients With Stage IV Melanoma (NCT00052156) | CancerVax Corporation | |
| Vaccine Therapy for Patients With Stage III Melanoma (NCT00052130) | CancerVax Corporation |
Track CancerVax Corporation automatically
Every clearance here is in the API, with alerts when new ones post.